Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


VasoStitch Inc.

Access and closure systems for minimally invasive valve replacement and repair

This article was originally published in Start Up

Executive Summary

Delivering valve devices to a structurally damaged heart through the femoral artery can be a tricky proposition. Cardiologists normally gain access through a large incision and employ balloons to increase the diameter of the aperture. Problems can arise when trying to close the hole at the end of the procedure. New technology from VasoStitch Inc. allows for simpler and safer access and closure of catheter-based interventions for minimally invasive valve replacement and repair. The start-up’s two devices, yet to be branded, are for accessing the heart through the femoral artery (transfemorally) and the chest wall (transapically), respectively

You may also be interested in...

Amir Belson: Stealth Medtech Entrepreneur

Amir Belson is among the most prolific device entrepreneurs in the industry today, having launched a dozen companies in the past 12 years. Not as well-known as other physician-inventors, he combines an aggressive IP strategy with an innovative approach to early-stage financing to launch companies in a variety of clinical spaces.

ZipLine Medical Inc.

For many years, non-absorbable and absorbable sutures and staples have been the primary method of closing the external skin layer. Both types of devices provide good incision closure to promote wound healing, but they have drawbacks. There hasn't been much innovation in incision closure over the last decade, but now, innovative companies are working to address concerns with the gold standards. ZipLine Medical Inc. hopes to be at the forefront of this evolution with a noninvasive, external skin closure system intended as an alternative to sutures and staples that decreases operating time, heals the wound in a uniform manner with minimum skin stress and a much-improved aesthetic result and is easily removed by the patient at home.

Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug

The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts